14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
NTRA vs TEM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
NTRA Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–1 Matrix Metrics)
NTRA Overall Winner
6-Pillar Tally: NTRA 3 – 3 TEM
Matrix Metrics: NTRA 7 – 1 TEM
As of Nov 17, 2026, Natera, Inc. (NTRA) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NTRA carries a Unified Composite Score of 46.5/100 (HOLD) at $287.47 (N/M Forward P/E, -8.5% operating margin), whereas TEM carries 43.5/100 (HOLD) at $63.43 (N/M Forward P/E, -18.5% operating margin).
Technical & Structure Timing Caution: NTRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 27.6); meanwhile TEM is in a Breakdown options structure phase (RSI 40.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NTRA Moat ProfileCyclical / Execution-Driven Positioning
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $46.3B market capitalization and -8.5% operating margin.
OpEx & R&D Reinvestment73.6% of Rev ($2.14B)
90D Engineering Disclosures0 Published
TEM Moat ProfileEcosystem & Network-Effect Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $13.1B market capitalization and -18.5% operating margin.
OpEx & R&D Reinvestment83.0% of Rev ($1.25B)
90D Engineering Disclosures0 Published · AI Drug Discovery
Investor FAQ NTRA vs TEM Key Questions & Quantitative Answers
As of Nov 17, 2026, Natera, Inc. (NTRA) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). NTRA carries a Unified Composite Score of 46.5/100 (HOLD) at $287.47 (N/M Forward P/E, -8.5% operating margin), whereas TEM carries 43.5/100 (HOLD) at $63.43 (N/M Forward P/E, -18.5% operating margin). Technical & Structure Timing Caution: NTRA trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 27.6); meanwhile TEM is in a Breakdown options structure phase (RSI 40.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NTRA leads the Growth & Scale pillar: NTRA posts +34.1% YoY revenue growth and +0.0% YoY earnings growth on $2.91B TTM revenue (65.1% gross margin, -8.5% operating margin), compared with TEM at +23.1% YoY revenue growth and +0.0% YoY earnings growth on $1.51B TTM revenue (64.5% gross margin, -18.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), NTRA cumulative revenue shifted +788.5% while TEM shifted +296.9%. In operating R&D and SG&A reinvestment, NTRA deploys 73.6% of Rev ($2.14B) (0 90-day corporate R&D disclosures) versus 83.0% of Rev ($1.25B) (0 disclosures) for TEM.
TEM screens cheaper on headline valuation multiples. NTRA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 15.6x EV/Revenue (1.1% FCF margin), whereas TEM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.2x EV/Revenue (-10.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against NTRA (-10.5% ROE) versus TEM (-37.5% ROE) capital efficiency.
In options market volatility and institutional positioning, NTRA carries 57.7% implied volatility (30th %ile, Balanced (25th–60th %ile)), a 1.04x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.52β · 76% Vol realized risk). By comparison, TEM carries 99.3% implied volatility (44th %ile, Balanced (25th–60th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.51β · 93% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.